DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.

N Engl J Med 1998;
338 (21) 1488-1497

Download Bibliographical Data

Search in:
Access:
Access: